President Nan Keohane announced Friday the members of the search committee that will select the successor for Chancellor of Health Affairs Dr. Ralph Snyderman, also president and CEO of the Duke University Health System.
Roy Bostock, a former Trustee and a founding member of the DUHS board of directors, will chair the 13-member committee. Dr. Charles Hammond, former chair of obstetrics and gynecology, will serve as vice-chair.
The committee will also be composed of seven faculty members, one medical student, one representative from Durham, one administrator and one Trustee.
Snyderman announced in March that he would step down in June 2004, in tandem with Keohane's planned departure from the University in the same month.
"This is a crucially important leadership position at Duke. I am confident we will attract a recognized leader to one of the most attractive and dynamic leadership roles in all of academic medicine," Keohane said in a statement.
Allison Haltom, university secretary, said there would be coordination between the replacement search committees for Keohane and Snyderman, although the presidential selection will be announced first. Following the selection of the new president, Keohane and her successor will have a chance to interview the candidates [for chancellor of health affairs] and make a decision, she added.
"Given the importance of that search to the University, one of the things that both President Keohane and Chancellor Snyderman [thought] was by starting the presidential search early enough, the hope is to have the new president selected by the time the final candidates are known for the Chancellor search, so the new president can play a role, and the Chancellor candidate can know who their boss is going to be," said Senior Vice President for Public Affairs and Government Relations John Burness.
The current timeline called for the new president to be selected in February 2004 and the chancellor to be selected within the two months thereafter.
In his 15-year tenure, Snyderman, a faculty member since 1972, increased both the size and prestige of the Medical Center and created the Health System enterprise, most notably marked by the acquisitions of Durham Regional Hospital and Raleigh Community Hospital.
The creations of the Duke Clinical Research Institute and the Institute for Genome Sciences and Policy also occurred under Snyderman's helm.
Bostock, who retired from the Board of Trustees and the chairmanship of the Trustees' Business and Finance Committee in July after 12 years of service, is also Chairman Emeritus of BCom3 Group Inc., a leading advertising and marketing communications holding company.
In addition to Bostock and Hammond, the members of the committee include: Ben Reese, vice president for institutional equity; Karl von der Heyden, member of the DUHS board of directors and chair of the Duke University Trustees' audit committee; Charles Blackmon, community representative, past president of the Durham County Hospital Corp. and a member of the DUHS Board of Directors; Dr. Nancy Allen, professor of medicine in rheumatology and immunology and chair of the Academic Council; Blanche Capel, associate professor in cell biology; Elizabeth Clipp, professor in the School of Nursing; Daniel Kiehart, professor of biology; William Mitchell, professor in the Fuqua School of Business; Dr. Joseph Moore, professor of medicine in oncology and transplant services; Dr. Dale Purves, former chair of neurobiology; and James Brashears, medical school student. Haltom will serve as a non-voting ex-officio member of the committee, as she does on the presidential search committee.
Get The Chronicle straight to your inbox
Signup for our weekly newsletter. Cancel at any time.